Mechanisms and pharmaceutical action of lipid nanoformulation of natural bioactive compounds as efficient delivery systems in the therapy of osteoarthritis
Osteoarthritis (OA) is a degenerative joint disease. An objective of the nanomedicine and
drug delivery systems field is to design suitable pharmaceutical nanocarriers with …
drug delivery systems field is to design suitable pharmaceutical nanocarriers with …
Initial In Vitro Development of a Potassium-Based Intra-Articular Injection for Osteoarthritis
J Erndt-Marino, P Diaz-Rodriguez… - Tissue Engineering Part …, 2018 - liebertpub.com
The long-term goal of this work is to develop a potassium (K+)-based intra-articular (IA)
injection for osteoarthritis treatment. Within this context, the objectives of this study were to …
injection for osteoarthritis treatment. Within this context, the objectives of this study were to …
[图书][B] Toward Development of a Potassium (K+)-based Intra-articular Injection for Osteoarthritis Treatment
JD Erndt-Marino - 2018 - search.proquest.com
Osteoarthritis (OA) is characterized by a slow progression of cartilage erosion driven in part
by a cascade of inflammatory mediators produced from an activated synovium and the …
by a cascade of inflammatory mediators produced from an activated synovium and the …